The estimated net worth of Dr. Harlan S. Robins Ph.D. is at least $38,602,357 as of 7 Mar 2022. He owns shares worth
$3,862,065 as insider, has earned $31,002,042
from insider trading and has received compensation worth at least
$3,738,250 in Adaptive Biotechnologies Corporation.
What is the salary of Harlan S. Robins Ph.D.?
Dr. Harlan S. Robins Ph.D. salary is $747,650 per year
as Co-Founder & Chief Scientific Officer in Adaptive Biotechnologies Corporation.
How old is Harlan S. Robins Ph.D.?
Dr. Harlan S. Robins Ph.D. is 52 years old, born in 1973.
What stocks does Harlan S. Robins Ph.D. currently own?
As insider, Dr. Harlan S. Robins Ph.D. owns shares in one company:
What does Adaptive Biotechnologies Corporation do?
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers; and immunoSEQ T-MAP COVID for vaccine developers and researchers to measure the T-cell immune response to vaccines. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. It serves the life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Dr. Harlan S. Robins Ph.D. has made 80 insider trades between 2020-2022, according to the Form 4 filled with the SEC. Most recently he sold
4,517 units of ADPT stock worth $54,249 on 7 Mar 2022.
The largest trade he's
ever made was exercising 100,000 units of ADPT stock
on 19 Jan 2021. As of 7 Mar 2022
he still owns at least 311,960 units of ADPT stock.
Transaction
Date
Security
Shares
Price per share
Total value
Source
Sale
Common Stock
4,517
$12.01
$54,249
Sale
Common Stock
300
$31.36
$9,408
Option
Stock Option (Right to Buy)
4,000
$6.55
$26,200
Option
Common Stock
300
$6.55
$1,965
Option
Common Stock
3,700
$6.55
$24,235
Sale
Common Stock
3,700
$32.05
$118,585
Option
Stock Option (Right to Buy)
11,200
$6.55
$73,360
Option
Common Stock
3,700
$6.55
$24,235
Sale
Common Stock
3,700
$33.73
$124,801
Option
Common Stock
3,700
$6.55
$24,235
Sale
Common Stock
3,700
$33.71
$124,727
Sale
Common Stock
3,800
$33.34
$126,673
Option
Common Stock
3,800
$6.55
$24,890
Option
Stock Option (Right to Buy)
11,685
$6.32
$73,849
Sale
Common Stock
3,895
$32.96
$128,379
Option
Common Stock
3,895
$6.32
$24,616
Sale
Common Stock
3,895
$33.09
$128,886
Option
Common Stock
3,895
$6.32
$24,616
Option
Common Stock
3,895
$6.32
$24,616
Sale
Common Stock
3,895
$32.27
$125,692
Sale
Common Stock
3,895
$36.88
$143,628
Option
Stock Option (Right to Buy)
3,895
$6.32
$24,616
Option
Common Stock
3,895
$36.88
$143,628
Sale
Common Stock
3,895
$6.32
$24,616
Option
Common Stock
3,895
$6.32
$24,616
Sale
Common Stock
3,895
$6.32
$24,616
Sale
Common Stock
3,895
$36.93
$143,823
Option
Stock Option (Right to Buy)
3,895
$6.32
$24,616
Option
Common Stock
3,895
$36.93
$143,823
Option
Common Stock
3,895
$6.32
$24,616
Option
Stock Option (Right to Buy)
3,895
$6.32
$24,616
Sale
Stock Option (Right to Buy)
2,995
$6.32
$18,928
Sale
Common Stock
900
$37.89
$34,101
Option
Stock Option (Right to Buy)
3,895
$6.32
$24,616
Sale
Common Stock
3,895
$6.32
$24,616
Option
Common Stock
3,895
$37.64
$146,608
Sale
Common Stock
3,895
$34.58
$134,670
Option
Stock Option (Right to Buy)
3,895
$6.32
$24,616
Option
Common Stock
3,895
$6.32
$24,616
Sale
Common Stock
3,895
$6.32
$24,616
Option
Common Stock
3,895
$6.32
$24,616
Option
Stock Option (Right to Buy)
3,895
$6.32
$24,616
Sale
Common Stock
3,895
$6.32
$24,616
Option
Common Stock
3,895
$6.32
$24,616
Option
Stock Option (Right to Buy)
3,895
$6.32
$24,616
Sale
Common Stock
3,895
$37.7
$146,842
Sale
Common Stock
3,895
N/A
N/A
Option
Stock Option (Right to Buy)
3,895
N/A
N/A
Option
Common Stock
3,895
N/A
N/A
Sale
Common Stock
3,895
$37.32
$145,342
Option
Common Stock
3,895
N/A
N/A
Sale
Common Stock
3,895
N/A
N/A
Option
Stock Option (Right to Buy)
3,895
N/A
N/A
Sale
Common Stock
3,895
N/A
N/A
Option
Stock Option (Right to Buy)
3,895
N/A
N/A
Option
Common Stock
3,895
N/A
N/A
Sale
Common Stock
3,895
$37.02
$144,173
Sale
Common Stock
3,895
$6.32
$24,616
Option
Stock Option (Right to Buy)
3,895
$6.32
$24,616
Option
Common Stock
3,895
$6.32
$24,616
Option
Common Stock
3,895
$6.32
$24,616
Sale
Common Stock
3,895
$37.32
$145,361
Sale
Common Stock
3,895
$37.32
$145,361
Option
Stock Option (Right to Buy)
3,895
$6.32
$24,616
Sale
Common Stock
3,895
$36.21
$141,018
Option
Common Stock
3,895
$6.32
$24,616
Sale
Common Stock
3,895
$36.21
$141,018
Option
Stock Option (Right to Buy)
3,895
$6.32
$24,616
Sale
Common Stock
3,895
$35.95
$140,006
Option
Common Stock
3,895
$6.32
$24,616
Option
Stock Option (Right to Buy)
3,895
$6.32
$24,616
Sale
Common Stock
3,195
$35.43
$113,199
Option
Common Stock
3,895
$6.32
$24,616
Option
Stock Option (Right to Buy)
3,895
$6.32
$24,616
Sale
Common Stock
3,895
N/A
N/A
Option
Stock Option (Right to Buy)
3,895
$6.32
$24,616
Sale
Common Stock
3,895
$36.4
$141,759
Option
Common Stock
3,895
$6.32
$24,616
Option
Common Stock
7,790
N/A
N/A
Option
Stock Option (Right to Buy)
7,790
N/A
N/A
Sale
Common Stock
7,790
$43.22
$336,684
Option
Stock Option (Right to Buy)
7,790
N/A
N/A
Option
Common Stock
7,790
$6.32
$49,233
Sale
Common Stock
7,790
$27.65
$215,417
Option
Common Stock
11,685
$6.32
$73,849
Option
Stock Option (Right to Buy)
11,685
$6.32
$73,849
Sale
Common Stock
11,685
$20.12
$235,102
Sale
Common Stock
5,290
N/A
N/A
Option
Stock Option (Right to Buy)
5,290
$6.32
$33,433
Option
Common Stock
5,290
N/A
N/A
Sale
Common Stock
6,395
$27.36
$174,986
Option
Stock Option (Right to Buy)
6,395
$6.32
$40,416
Option
Common Stock
6,395
$6.32
$40,416
Sale
Common Stock
6,395
$40.51
$259,042
Sale
Common Stock
7,790
$6.32
$49,233
Option
Stock Option (Right to Buy)
7,790
$6.32
$49,233
Option
Common Stock
7,790
$6.32
$49,233
Sale
Common Stock
7,790
$59.92
$466,738
Option
Stock Option (Right to Buy)
7,790
$6.32
$49,233
Option
Common Stock
7,790
$6.32
$49,233
Option
Common Stock
7,790
$6.32
$49,233
Option
Stock Option (Right to Buy)
7,790
$6.32
$49,233
Sale
Common Stock
7,790
$59.71
$465,141
Option
Common Stock
7,790
$6.32
$49,233
Option
Stock Option (Right to Buy)
7,790
$6.32
$49,233
Sale
Common Stock
7,790
$55.86
$435,149
Sale
Common Stock
23,370
$66.85
$1,562,284
Option
Stock Option (Right to Buy)
23,370
$6.32
$147,698
Option
Common Stock
23,370
$6.32
$147,698
Option
Stock Option (Right to Buy)
100,000
$6.44
$643,500
Option
Common Stock
50,000
$6.32
$316,000
Sale
Common Stock
20,394
$66.84
$1,363,135
Option
Stock Option (Right to Buy)
50,000
$6.55
$327,500
Sale
Common Stock
50,000
$67.48
$3,373,850
Option
Stock Option (Right to Buy)
50,000
$6.55
$327,500
Sale
Common Stock
50,000
$68.95
$3,447,400
Option
Stock Option (Right to Buy)
100,000
$6.44
$643,500
Option
Common Stock
50,000
$6.32
$316,000
Sale
Common Stock
11,100
$51.52
$571,839
Option
Common Stock
11,100
$6.32
$70,152
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Sale
Common Stock
11,100
$50.44
$559,884
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Option
Common Stock
11,100
$6.32
$70,152
Option
Common Stock
11,100
$6.32
$70,152
Sale
Common Stock
11,100
$50.59
$561,549
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Option
Common Stock
11,100
$6.32
$70,152
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Sale
Common Stock
11,100
$6.32
$70,152
Sale
Common Stock
11,100
$6.32
$70,152
Option
Common Stock
11,100
$6.32
$70,152
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Option
Common Stock
11,100
$6.32
$70,152
Sale
Common Stock
11,100
$52.36
$581,141
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Sale
Common Stock
11,100
$47.09
$522,666
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Option
Common Stock
11,100
$6.32
$70,152
Option
Common Stock
11,100
$6.32
$70,152
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Sale
Common Stock
11,100
$6.32
$70,152
Sale
Common Stock
11,100
$47.65
$528,860
Option
Common Stock
11,100
$6.32
$70,152
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Sale
Common Stock
11,100
$42.86
$475,746
Option
Common Stock
11,100
$6.32
$70,152
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Option
Common Stock
11,100
$6.32
$70,152
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Sale
Common Stock
11,100
$42.99
$477,189
Option
Common Stock
11,100
$6.32
$70,152
Sale
Common Stock
11,100
$42.34
$469,974
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Option
Common Stock
11,100
$6.32
$70,152
Sale
Common Stock
11,100
$39.49
$438,306
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Option
Common Stock
22,200
$6.32
$140,304
Sale
Common Stock
22,200
$39.66
$880,341
Option
Stock Option (Right to Buy)
22,200
$6.32
$140,304
Sale
Common Stock
11,100
$46.48
$515,961
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Option
Common Stock
11,100
$6.32
$70,152
Sale
Common Stock
11,100
$46.05
$511,155
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Option
Common Stock
11,100
$6.32
$70,152
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Sale
Common Stock
11,100
$46.58
$517,038
Option
Common Stock
11,100
$6.32
$70,152
Sale
Common Stock
1,500
$46.21
$69,315
Sale
Common Stock
31,372
$40.48
$1,269,939
Sale
Common Stock
38,628
$40.11
$1,549,369
Sale
Common Stock
11,100
$39.02
$433,067
Option
Stock Option (Right to Buy)
11,100
$6.32
$70,152
Option
Common Stock
11,100
$6.32
$70,152
Sale
Common Stock
35,400
$36.13
$1,279,144
Option
Stock Option (Right to Buy)
35,400
$6.32
$223,728
Option
Common Stock
35,400
$6.32
$223,728
Option
Stock Option (Right to Buy)
31,200
$6.32
$197,184
Sale
Common Stock
31,200
$34.85
$1,087,320
Option
Common Stock
31,200
$6.32
$197,184
Option
Common Stock
25,600
$6.32
$161,792
Sale
Common Stock
25,600
$29.96
$766,848
Option
Stock Option (Right to Buy)
25,600
$6.32
$161,792
Sale
Common Stock
3,900
$29.03
$113,198
Option
Common Stock
3,900
$6.32
$24,648
Option
Stock Option (Right to Buy)
3,900
$6.32
$24,648
Option
Common Stock
14,900
$6.32
$94,168
Sale
Common Stock
14,900
$28.64
$426,781
Option
Stock Option (Right to Buy)
14,900
$6.32
$94,168
Option
Stock Option (Right to Buy)
7,400
$6.32
$46,768
Option
Common Stock
7,400
$6.32
$46,768
Sale
Common Stock
7,400
$33.19
$245,606
Option
Stock Option (Right to Buy)
7,400
$6.32
$46,768
Option
Common Stock
7,400
$6.32
$46,768
Sale
Common Stock
7,400
$32.7
$241,943
Option
Stock Option (Right to Buy)
18,500
$6.32
$116,920
Sale
Common Stock
18,500
$6.32
$116,920
Option
Common Stock
18,500
$6.32
$116,920
Option
Stock Option (Right to Buy)
3,700
$6.32
$23,384
Sale
Common Stock
3,700
$27.82
$102,916
Option
Common Stock
3,700
$6.32
$23,384
Option
Common Stock
3,700
$6.32
$23,384
Sale
Common Stock
3,700
$27.49
$101,702
Option
Stock Option (Right to Buy)
3,700
$6.32
$23,384
Option
Common Stock
3,700
$6.32
$23,384
Sale
Common Stock
3,700
$6.32
$23,384
Option
Stock Option (Right to Buy)
3,700
$6.32
$23,384
Adaptive Biotechnologies key executives
Adaptive Biotechnologies Corporation executives and other stock owners filed with the SEC:
